Swine Flu death toll has touched 66, reports JP Nadda to Lok Sabha
Advertisement
66 people have reportedly died in June-July this year due to the swine fly as told by JP Nadda to the Lok Sabha
Union Health Minister, JP Nadda is reported to have told PTI that 66 people have lost their lives because of Swine Flu (H1N1 influenza) over the last two months this year. This figure is higher in comparison to the number reported during the same period last year.
J P Nadda further apprised the Lok Sabha that during the June-July period, 740 swine flu cases have been detected across the country. He said during the same period last year, 45 people had lost their lives out of 220 detected cases of swine flu.
As reported by PTI
"All the reported deaths may not have occurred only due to Influenza A H1N1 infection but may also be due to co-morbid conditions and the patients being immuno-compromised," he said during Question Hour.
Nadda said the recent cases were being reported from few states which have informed that they have sufficient stock of drug 'Oseltamivir'. The Ministry has also kept an emergency stock of Oseltamivir.
Union Health Minister, JP Nadda is reported to have told PTI that 66 people have lost their lives because of Swine Flu (H1N1 influenza) over the last two months this year. This figure is higher in comparison to the number reported during the same period last year.
J P Nadda further apprised the Lok Sabha that during the June-July period, 740 swine flu cases have been detected across the country. He said during the same period last year, 45 people had lost their lives out of 220 detected cases of swine flu.
As reported by PTI
"All the reported deaths may not have occurred only due to Influenza A H1N1 infection but may also be due to co-morbid conditions and the patients being immuno-compromised," he said during Question Hour.
Nadda said the recent cases were being reported from few states which have informed that they have sufficient stock of drug 'Oseltamivir'. The Ministry has also kept an emergency stock of Oseltamivir.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.